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During heavy exercise in chronic obstructive pulmonary disease (COPD), dynamic airways
compression leads to a progressive fall in intrabreath flow. This is manifested by concavity
in the spontaneous expiratory flowevolume (SEFV) curve. We developed a method to quantify
the SEFV curve configuration breath-by-breath during incremental exercise utilizing a comput-
erized analysis. The flow signal was digitized at 100 Hz. For each breath’s SEFV curve, points of
highest flow ( _Vmax) and end-expiration ( _VEE) were identified to define a rectangle’s diagonal.
Fractional area within the rectangle below the SEFV curve was defined as the ‘‘rectangular
area ratio’’ (RAR); RAR <0.5 signifies concavity of the SEFV. To illustrate the utility of this
method, time courses of RAR during incremental exercise in 12 healthy and 17 COPD individuals
(FEV1 %Pred.Z 39 12) were compared. SEFV in healthy individuals manifested progressively
more convex SEFV curves throughout exercise (RARZ 0.56 0.08 at rest and 0.61 0.05 at
peak exercise), but became progressively more concave in COPD patients (RARZ 0.52 0.08
at rest and 0.46 0.06 at peak exercise). In conclusion, breath-by-breath quantification of
SEFV curve concavity describes progressive shape changes denoting expiratory flow limitation
during incremental exercise in COPD patients. Further studies are warranted to establish
whether this novel method can be a reliable indicator of expiratory flow limitation during exer-
cise and to examine the relationship of RAR time course to the development of dynamic hyper-
inflation.
ª 2009 Elsevier Ltd. All rights reserved.222 8200; fax: þ1 310 222 8249.
(R. Casaburi).
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Exercise intolerance in COPD patients is a common
disabling complaint, which is particularly prominent in
severe states.1 An important determinant of exercise
intolerance in patients with severe COPD is reduced
ventilatory capacity, largely dictated by expiratory flow
limitation (EFL) induced by elevated airway resistance and
decreased elastic recoil.2e5
The principal contributor of EFL is increased airway
resistance as it propagates a cascade of changes in other
modulators of airflow.6 Elevation of resistance lengthens
the ventilatory time constants of the airways and neces-
sitates increased intrathoracic pressure to drive flow.7
Higher pressures, in turn, augment gas compression and
dynamic airway compression in the system.8e10 All of these
factors lead to intrabreath reduction of flow2,4,8e10 mani-
festing in concave shape of the expiratory flowevolume
curve e an indication that flow falls quickly as expiration
proceeds.
Several approaches have sought to assess EFL during
exercise.11e15 One method takes advantage of the fact that
EFL exists when expiratory flow becomes independent of
driving pressure so that flow does not increase when
negative expiratory pressure (NEP) is applied at the
mouth.13 Another method used to detect EFL is the forced
oscillation technique, which relies on the concept that
oscillatory pressure cannot pass through flow-limiting
airway segments, thereby resulting in reduced apparent
compliance and respiratory system input reactance.14
Although both NEP and forced oscillation techniques offer
the means to quantify EFL during spontaneous breathing,
the implementation of either method poses challenges for
continuous quantification over the course of exercise. The
forced oscillation technique requires complex instrumen-
tation and special maneuvers.15 The NEP method does not
allow assessment of breath-by-breath changes in EFL
because the method necessitates comparison of the flow
profiles of expirations with and without the application of
NEP14,15 usually taken several breaths apart.
Given the fact that the expiratory limb of the flowe
volume loop in a classic forced expiratory spirometry shows
concavity in patients with obstructive airway disease and
that concavity increases with severity of airflow obstruc-
tion, we hypothesized that EFL can be assessed quantita-
tively by examining the configuration of spontaneous
expiratory flowevolume (SEFV) curves during rest and
exercise on a breath-by-breath basis. In concept, this
method does not require instructed breathing or modifica-
tion of the usual procedures used in cardiopulmonary
exercise testing.16,17 Information relevant to EFL can be
gathered from the shape of SEFV curves because, as stated
above, changes in the variables governing EFL (i.e. dynamic
airway compression, gas compression, and lung unit time
constants) are predictably reflected in intrabreath changes
of flow. Moreover, in presence of EFL, flow rates of spon-
taneous expirations are governed by mechanisms similar to
those influencing forced expirations,10,18 which have been
previously used to characterize EFL.19e22 This implies that
the shape of SEFV curves, especially the degree of its
concavity, might be useful to quantify the progression ofEFL as exercise intensifies and the minute ventilation
approaches breathing capacity.
In this methodological study, we aimed to develop
computerized procedures to quantify the configuration of
the spontaneous flowevolume profile on a breath-by-
breath basis throughout the progression of incremental
exercise, with special reference to the development of EFL
in moderate to severe COPD patients. To gain a preliminary
appreciation of the potential of this technique, and before
comparing it with the above-mentioned known methods,
we also compared the spontaneous expiratory flowevolume
responses in a group of COPD patients and a group of age-
matched healthy individuals. In addition, we examined the
relation between the degree of SEFV curve concavity and
measures of ventilatory limitation during exercise (i.e.
_VE/MVV).
Materials and methods
Study subjects
Seventeen men and women with the diagnosis of
moderate to severe COPD were recruited. We included
COPD individuals with forced expiratory volume in one
second (FEV1) 60% of predicted as determined by the
Hankinson reference equations.23 We excluded individuals
with acute respiratory exacerbation, those with diagnosis
or symptoms of significant cardiac disease, those requiring
chronic supplemental oxygen, those with resting oxygen
saturation <89% measured by pulse oximetry, and those
who were exercise-limited by orthopedic or joint related
diseases. Twelve healthy age-matched men and women
were also recruited. All subjects signed the written
informed consent for their participation in the study as
approved by the Institutional Review Board of the Los
Angeles Biomedical Research Institute at Harbor-UCLA
Medical Center.
Pulmonary function and exercise tests
Each subject underwent resting spirometry (Vmax 229,
VIASYS Sensormedics, Yorba Linda, California, USA). COPD
patients took 400 mg of albuterol by inhalation 20 min
before testing in order to maximize bronchodilation.
Maximum voluntary ventilation (MVV) was calculated as
FEV1 40.24 Lung volumes were measured using constant
volume body plethysmograph (AutoBox 6200 D, VMax,
SensorMedics). All pulmonary function tests fulfilled the
ATS/ERS guidelines.25
An incremental symptom-limited exercise test was per-
formed on an electrically braked cycle ergometer (Ergoline
800, VIASYS SensorMedics) with a pedaling rate of 60
revolutions per minute. After 3 min of rest and 3 min of
loadless pedaling, the work rate was increased by 5e15
watts (W) per minute in a ramp fashion (increment was
5 W/min if FEV1< 1.0 L, 10 W/min if FEV1> 1.0 L for the
COPD patients; increment rate was 15 W/min for the
healthy subjects). Participants were asked to continue to
exercise up to the limit of tolerance, marked by inability
(despite encouragement) to maintain pedaling frequency or
Spontaneous flowevolume curves during exercise in COPD 391occurrence of intolerable shortness of breath. Shortness of
breath and leg fatigue were assessed by the Borg category
ratio scale every two minutes during exercise.26
Data collection
Respiratory gas exchange (minute ventilation _VE, oxygen
uptake VO2, CO2 output VCO2) were measured breath-by-
breath by a commercial exercise system (Vmax Spectra,
SensorMedics). The analog flow signal from the exercise
system was digitized using a 16-bit A/D converter (WinDaq
Acquisition Version 2.68, Dataq Instruments, Akron, Ohio,
USA) at 100 Hz and stored on a personal computer for off-
line analysis. Volume was derived by integrating the flow
signal and was calibrated subsequently. The system cali-
bration was demonstrated to be linear and to have zero
intercept; therefore, a scalar multiplicative calibration
factor was applied to adjust the computed expired volume
from the flow signal.
Breath-cycle detection
Because flow toward the end of expiration often fluctuates
around zero, it was unsatisfactory to apply a ‘‘crossing zero
flow’’ criterion to discern the start and the end of a breath
cycle. To overcome this, we moved the trigger-threshold to
a small negative flow (0.15 L/s). We defined the start of
expiration as the point at which flow exceeded this
threshold and was followed by a clear positive trend in the
next 140 ms. Similarly, we defined the start of inspiration as
the point at which flow exceeded this negative threshold,
followed by a clear negative trend in the next 140 ms.
Computing the tidal volume during spontaneous
respiration
Tidal volume calculation was accomplished by resetting the
volume integration by using the Riemann Sums method at
the start of each expiration.27 This compensated for
predictable inequalities in inspiratory and expiratory inte-
grated volumes when the respiratory quotient differs from
unity.
Computing the rectangular area ratio (RAR)
Spontaneous expiratory flowevolume curves were exam-
ined breath-by-breath, and a geometric analysis was per-
formed by custom-made Sigma Plot 10.0 transform
functions (SPSS Science, Chicago, IL). The geometric anal-
ysis was designed to examine the changes in the shape of
the descending phase of the expiratory limb of the SEFV
curves. The geometric analysis was based upon the identi-
fication of the intra-breath coordinates of two critical
anchoring points: (A) the maximum spontaneous expiratory
flow ( _Vmax) and (B) the point at which the expiratory flow
takes a sharp decline signaling the beginning of inspiration
( _VEE, ‘end-expiratory flow’) (Fig. 1). _VEE was defined as the
point associated with the greatest difference between the
slopes of adjacent 20 ms segments of the flowevolume
curve during the last 0.25 s of expiration. These two points
were used to anchor a rectangle from which the breath-by-breath rectangular area ratio (RAR) was calculated as
a measure of concavity defined in the following way:
RARZ
R V@ _VEE
V@ _Vmax
_VdV  ð _VEE  VT

VTð _Vmax  _VEEÞ
;
where V@ _Vmax and V@ _VEE are the volumes at _Vmax and _VEE,
respectively and VT is tidal volume. Values of RAR below 0.5
signify concavity while values above 0.5 signify convexity.
This quantification makes comparisons of curvatures
between different loops possible (Fig. 1).
All computer algorithms were developed using Sigma
Plot transform functions (SPSS Science, Chicago, IL, USA)
for breath detection and for the breath-by-breath deter-
mination of the parameters of the geometric analysis (RAR,
_Vmax, _VEE and the relative position of _Vmax). We report
these variables in 30-s bin averages.
Statistical analysis
The results are presented as mean SD in the text and
tables and plotted as mean SEM in the figures, unless
noted otherwise. Group means were compared by unpaired
two-tailed Student’s t-tests. To compare means between
the two groups at different levels of exercise, we used two
way repeated measures ANOVA with Holm-Sidak post-hoc
analysis of variance to detect any individual significance.
The statistical analyses were performed in SigmaStat 3.5
(SPSS Science). Statistical significance was accepted at
P< 0.05.
Results
Subject characteristics and exercise tolerance
The demographic and resting spirometric findings of the
study population are presented in Table 1. The resting
pulmonary function showed a moderate to severe obstruc-
tion in the COPD patients. There were no statistically
significant differences in age, height, and weight between
the healthy and COPD groups.
Table 2 shows that, unlike the healthy individuals, COPD
patients had a severely reduced exercise tolerance with
marked ventilatory limitation as characterized by high end-
exercise minute ventilation ( _VE peak) to MVV ratio
( _VE peak/MVV; 95 21% vs. 54 8% in the COPD patients vs.
healthy individuals, respectively; P< 0.05).
Breath-cycle validation
As a validation procedure for breath cycle detection, each
data set was visually inspected for accuracy and validity of
breathing phase change and was manually corrected if
necessary. Thus, we were able to count the number of false
positive and false negative detections and calculate the
sensitivity for detecting the start of expirations and inspi-
rations. Among the 29 studies, the false positive detection
rate for inspiration and expiration were 1.2 1.1% and
1.9 1.3%, respectively. The false negative rate was
4.2 4.4% for inspirations and 5.0 4.5% for expirations.
Figure 1 Progression of the spontaneous flowevolume (SEFV) curve configuration during incremental exercise. Top row:
a healthy individual (FEV1Z 3.7 L, 81% predicted). Bottom row: a severe COPD patient (FEV1Z 1.0 L, 29% predicted). The shaded
portion is the area used to calculate the rectangular area ratio (RAR); the triangle bounded by the dotted line, using the peak
expiratory flow ( _Vmax) and the end expiratory flow ( _VEE) as anchor points, represents an RAR of 0.5, demonstrating no curvature.
The healthy individual has an RAR that remains above 0.5, indicating SEFV curves with consistently convex profiles at all exercise
levels. The COPD patient displays a declining RAR that achieves a minimum of 0.34 at peak exercise, indicating a markedly concave
SEFV curve configuration as exercise progresses. Note that both the normal individual and the COPD patient increase intrabreath
_Vmax and _VEE with progression of exercise and that the position of _Vmax stays in the middle segment of the tidal volume in the
healthy subject, while remaining within the first quarter of expiration in the COPD patient. PWR: peak work rate, WR: work rate,
_VE: minute ventilation, MVV: maximal voluntary ventilation calculated as FEV1 40.
Table 1 Demographic and pulmonary function charac-
teristics of the study subjects.
Healthy (nZ 12) COPD (nZ 17)
Age (yrs) 60 9 63 10
Height (cm) 169 9 169 10
Weight (kg) 74 15 77 12
FEV1 (L) 3.1 0.8 1.1 0.5*
FEV1 %Pred. 104 13 39 12*
FVC (L) 4.0 1.0 2.8 1.1*
FVC %Pred. 103 14 77 20*
FEV1/FVC% 77 4 40 7*
MVV (L) 123.5 31.1 43.7 18.9*
PEF (L/s) 7.6 1.9 3.3 0.9*
TLC (L) 6.3 1.3 7.1 2.1
TLC %Pred. 108 12.9 113 17.8
FRC (L) 3.2 0.7 4.8 1.5*
FRC %Pred. 104 23.1 146 29.4*
RV (L) 2.3 0.5 3.8 1.4*
RV %Pred. 107 16.8 163 46.8*
%Pred. values in pulmonary function were calculated according
to reference equations of Hankinson et al.23 FEV1: forced
expiratory volume in the 1st s; FVC: forced viral capacity; MVV:
maximum voluntary ventilation (FEV1 40)24; PEF: peak expi-
ratory flow; TLC: total lung capacity; FRC: functional residual
capacity; RV: residual volume. *P< 0.05.
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manual correction of all these errors in breath detection.
Progressive change in the shape of the spontaneous
flowevolume curve during exercise
An animated sample demonstrating the occurrence of
‘buckling’ of the spontaneous expiratory flowevolume
curve as exercise proceeds is presented in Supplementary
data. Fig. 1 shows the expiratory phase of the flowevolume
loop at rest and at 25%, 75%, and 100% of peak work rate in
a typical healthy individual (upper row) and in a COPD
patient (lower row). The shape of the expiratory limb of the
SEFV curve at rest and during exercise in the healthy indi-
vidual is convex, which is reflected by an RAR 0.5 (Fig. 1,
upper row). But in the COPD patient, the expiratory limb of
the SEFV curve becomes concave at 75% peak work rate
(RARZ 0.4) and shows more concavity at peak exercise
(RARZ 0.34) (Fig. 1, lower row). Note that both the normal
individual and the COPD patient increase intrabreath _Vmax
and _VEE with progression of exercise and that the position
of _Vmax stays in the middle segment of the tidal volume in
the healthy subject, while remaining within the first
quarter of expiration in the COPD patient.
Fig. 2 illustrates the breath-by-breath analysis of the
RAR, _Vmax and _VEE during the time course of unloaded
cycling and incremental exercise in a healthy individual
(upper panel) and a COPD patient (lower panel).
Table 2 Exercise tolerance and end-exercise ventilatory
characterization (mean SD).
Healthy (nZ 12) COPD (nZ 17)
Peak WR (W) 145 38 68 35*
_VO2 peak (L/min) 1.75 0.49 1.14 0.37*
_VE peak (L/min) 66 19 40 14*
_VE peak/MVV (%) 54 8 95 21*
VT (L) at end-exercise 2.1 0.54 1.2 0.38*
RAR at end-exercise 0.61 0.05 0.46 0.06*
Peak WR: peak work rate in the incremental test; _VO2 peak: peak
oxygen uptake at end exercise; _VE peak: peak minute ventila-
tion; _VE=MVV: ratio of peak minute ventilation and maximal
voluntary ventilation (MVVZ FEV1 40)24; RAR: rectangular
area ratio; VT: tidal volume; *P< 0.05.
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lated by a negative exponential smoothing method.28 As
seen in the upper panel of Fig. 2, in a healthy individual,
the RAR smoothed curve of a healthy individual was above
the 0.5 line at rest and throughout the exercise, reflecting
the convexity of the SEFV curve during the test. Similarly,
the lower panel of Fig. 2 shows that during unloaded cycling
and early into the ramp exercise, the RAR smoothed curve
in the COPD patient was at or above the 0.5 line, reflecting
the convex shape of the expiratory limb of the SEFV curve.
At about 5 min into the incremental exercise test, the RAR
smooth curve fell below 0.5, signifying that the SEFV curve
became concave. The RAR ultimately reached a nadir of
0.37 at peak exercise in this COPD patient. It can be seen
that, at the time when the RAR smoothed curve fell below
0.5, _Vmax reached about 1.5 L/s and _VEE was appreciably
above the resting level.
Fig. 3 shows, in both healthy and COPD individuals, the
mean RAR plotted as a function of _VE max/MVV at rest and
during exercise: at 6, 4, and 2 min before end-exercise and
at end-exercise. In healthy individuals (empty circles), RAR
at 6 min before end-exercise dipped below the RAR at rest
but subsequently progressively increased during the
remainder of the test; RAR remained significantly above 0.5
throughout exercise. In marked contrast, average RAR of
COPD patients at rest was slightly higher than 0.5 but then
showed a continuous declining pattern throughout the
exercise (average peak exercise value 0.46 0.06). Fig. 3
also shows that, on average, the COPD patients used more
than 90% of their respiratory reserve (i.e. they are venti-
latory limited) at peak exercise.
We determined the number of COPD patients who showed
average RAR during the last 30 s before exercise end of<0.5.
We found that 14 out of 17 COPD patients manifested
averaged RAR< 0.5 at end exercise, although in two of the
14 patients the nadir value was only slightly below 0.5
(approximately 0.49). We sought factors responsible for the
failure to develop substantial concavity in these five COPD
patients. These patients spanned the range of disease
severity (i.e. FEV1% predicted of 33, 34, 45, 52 and 56);
hence, resting lung function does not seem to be a prime
determinant of concavity in the SEFV curve during exercise.
Two of the five had apparent ventilatory limitation (peak
_VE/MVV%Z 103 and 109) and three had substantial venti-
latory reserve (mean _VE/MVV%Z 70 8) at peak exercise.Compared to the other 12 COPD patients who developed
clear concavity during exercise, these five patients tended
to be less dyspneic (Borg dyspnea score: 5.5 1.9 vs.
4.8 1.5) and tended to exhibit more leg fatigue (Borg leg
score: 4.8 2.0 vs. 5.8 1.6) at peak exercise, though these
differences did not reach statistical significance. None of
the healthy individuals generated a RAR smoothed curve
that fell below 0.5 at any point during exercise.Discussion
We have shown that our novel, computerized algorithm
allows non-invasive and unobtrusive detection and charac-
terization of the genesis and development of progressive
expiratory flow limitation that occurs during exercise in
COPD patients. To the best of our knowledge, this is the
first approach that allows quantification of EFL on a breath-
by-breath basis by characterizing the profile of the SEFV
curve. Unlike NEP measurement and the forced oscillation
technique, our method does not require additional instru-
mentation beyond the flow sensor and digitizing equipment
for the analog output of the flow sensor. The algorithm for
this analysis might be implemented as a software module in
preexisting computerized cardiopulmonary exercise
systems. Furthermore, this method does not require
instructed maneuvers and provides a fully quantitative,
objective and dynamic measurement of developing flow
limitation during exercise on a breath-by-breath basis.
In contrast to our new quantitative method, previous
analyses of the shape of spontaneous flowevolume loop
have been mainly limited to qualitative inspection. Morris
and Lane first commented on the shape of the SEFV curve,
noting that a non-sinusoidal expiratory flow pattern was
indicative of obstruction, and pointed out that as EFL
progresses the _Vmax is reached earlier in the tidal breath.
29
Bardoczky and d’Hollander observed spontaneous flowe
volume profiles of anaesthetized patients, pointing out the
‘‘bowing configuration’’ in the expiratory limb as an indi-
cation of diffuse obstruction.30 Further, Baydur and Milic-
Emili qualitatively assessed the flowevolume shape in
association with the NEP method31 and observed SEFV curve
concavity in patients with a high percentage of tidal volume
exhibiting flow-limitation according to NEP; they reported
that two-thirds of the patients with SEFV curve concavity
had >50% of tidal volume exhibiting flow-limitation, and
half of the patients showing concavity had >70% of tidal
volume exhibiting flow limitation.
In our study, 14 of 17 COPD patients exhibited a value of
RAR <0.5 before peak exercise; however, there were five
subjects with low FEV1 who did not manifest substantial
concavity in their SEFV curve. Conversely, in none of the
normal subjects did the RAR smoothed curve drop below 0.5
at any point of exercise. By studying an age-matched control
group, we have largely eliminated the possibility that the
normally occurring decrease in elastic recoil with ageing
might be associated with these configuration changes.
There is, however, a wide range of subjects who ach-
ieved ‘minimal’ RAR at peak exercise in the COPD group,
and it is worthwhile to consider possible mechanisms of
concavity that might lead to this variability. Several factors
can be hypothesized to lead to concavity of the SEFV curve.
Figure 2 Breath-by-breath time course (open circles) of rectangular area ratio (RAR), peak expiratory flow ( _Vmax) and end-
expiratory flow ( _VEE) during an incremental exercise test. The heavy lines represent smoothed data (exponential method
32). Note
that the ordinate scales for _Vmax and _VEE are different in order to better represent the changes. Panel A: a healthy person (51 yrs,
female, FEV1: 2.72 L (98% predicted)). Panel B: a COPD patient (66 yrs, male, FEV1: 1.02 L (29% predicted)).
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flow rate caused by dynamic airway compression.8,14,18 The
drop in expiratory flow rate is exacerbated by rapid and
shallow breathing adopted by COPD patients, which is at
a frequency that limits effective ventilation to lung
compartments with short time constants. Our data show
that, as _Vmax rises during exercise, there is a shift of the
position of the _Vmax to an earlier position in the expired
volume, as previously observed by Morris and Lane.29
Concavity might also result from gas compression, which
largely depends on intrathoracic pressures achieved during
expiration.9 Therefore, gas compression might occur in the
presence of expiratory flow limitation.9,13 The configura-
tional changes might also be consistent with an increasing
role of active expiration in moderate to severe COPD
patients. Further studies are warranted to determine the
relative contribution of these potential mechanisms.
The ‘‘breath cycle determination’’ algorithm was one of
the critical development tasks for this analysis. It isgenerally agreed that using a slightly negative threshold is
adequate to eliminate the influence of noisy flow signal
toward the end of expiration. With the adoption of
a slightly negative flow threshold to detect the beginning
and end of expiration, post-detection visual inspection of
approximately 14,000 flowevolume loops demonstrated
that we achieved a low false positive and false negative
rate in determining both inspirations and expirations. This
finding indicates that in subsequent studies, visual confir-
mation of accurate breath detection by this algorithm will
not be needed.
A potential limitation of RAR measurement technique is
that noise in the expiratory flow signal interferes with
accurate determination of the anchoring points ( _Vmax and
_VEE), resulting in a rather significant scatter. Another
possible reason for the variability in RAR is breath-by-breath
physiologic variability in the exhalation, which results in
various degrees of concavity or convexity of the expiratory
limb of SEFV curve. Furthermore, we observed that the
Figure 3 Rectangular area ratio (RAR) responses occurring at
rest and as exercise limitation is approached during incre-
mental exercise in healthy individuals (nZ 12, open circles)
and COPD patients (nZ 17, closed circles). The abscissa
presents mean _VE/MVV at rest and at 6, 4, 2 and 0 min prior to
end-exercise from left to right, respectively. RAR values of
COPD patients are lower at rest and at all phases of exercise as
compared to normal, non-obstructed subjects (repeated
measures ANOVA P< 0.01). The RAR is significantly less than at
rest starting 4 min before end-exercise (repeated measures
ANOVA P< 0.01). In normal subjects, RAR is significantly higher
than at rest starting two minutes prior to end of exercise
(repeated measures ANOVA P< 0.01). The index of ventilatory
limitation ( _VE/MVV 100) approaches a value of 100% in the
COPD patients but not in the healthy individuals.
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between subsequent breaths that might lead to errors in
determining the critical anchoring points for the calculation
of RAR. Interestingly, the breath-to-breath variability was
generally greater in healthy subjects than in COPD patients.
We speculate that part of this variability might come from
random changes in compliance or vibrations within the
airways that is less characteristic in COPD. Additionally, the
SEFV curve adopts more convex configuration in healthy
subjects,29 from which it is more difficult to separate the
intrabreath peak- and end-expiratory flow, leading to vari-
ability in RAR calculations. In order to minimize the effect of
breath-by-breath variability, we smoothed the breath-by-
breath data using a single component exponential smoothing
method32 which allowed characterization of trends. Another
way of diminishing the effect of breath-to-breath configu-
ration changes of the SEFV curvewould be to average several
consecutive breaths and calculate the RAR based on the
averaged curves. A third way of dealing with this variability
would be to exclude from further analysis RAR values that
were outliers from the general trend. These methods might
be explored in future studies.
In summary, breath-by-breath quantification of
concavity of the expiratory limb of the SEFV curve by means
of calculation of the RAR seems to be a suitable method for
assessing development of EFL in COPD patients. Such
configuration changes are the result of progressively active
expiration and dynamic airway compression. Hence, it is
plausible that measurement of RAR may have clinical
implications in routine assessment of progressive flow
limitation in COPD and may help to define criticalventilatory limitation and dyspnea. Further studies are
warranted to compare the results of this breath-by-breath
quantification method with other methods of EFL deter-
mination such as the NEP method and the forced oscillation
technique and to explore the validity and reliability of this
method in stratification of COPD patients across the total
spectrum of disease severity. It will also be important to
examine the association of the SEFV configuration changes
with dynamic hyperinflation as a possible mechanism of the
observed SEFV concavity during exercise.
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The animated mpg file was recorded from a subject
performing a 5 W incremental exercise test to the limit
of tolerance. The spirometry of this 61 yrs old female
COPD subject showed, FEV1: 0.98 L (38% predicted),
FVC: 2.06 L (67% predicted) and FEV1/FVC: 48%. This
patient’s test from a preliminary study was not part of
the group of COPD patients presented in this article.
Expiratory flow deflects upward and expiratory volume
deflects rightward along the arbitrary scales. The 45 s
animation replays the digitized data on about 1:10
time compression. At the start of the record the
expiratory flow linearly decreases as expiration prog-
resses. As exercise starts (at about 6 s into the
animation) the peak expiratory flow of the sponta-
neous expiration starts increasing. A clear ‘buckling’
starts to occur in the middle segment of expiration (at
about 18 s) lending a concave shape of the flowe
volume curve. As a result of the ‘peaked’ maximal
expiratory flow and the ‘buckling’ the spontaneous
expiratory flowevolume curve starts to resemble to
that seen during maximal effort spirometry. The
incremental exercise ends at about 35 s. The buckling
continues to be present during recovery. Note that the
animated flowevolume loops are not aligned to total
lung capacity and that wandering along the X axis is
mainly due to changing differences in inspiratory and
expiratory tidal volumes.
Supplementary data associated with this article can
be found in the online version, at doi:10.1016/j.rmed.
2009.10.014.
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